In: European Heart Journal, 2010, vol. 31, no. 5, p. 560-560
|
In: European Heart Journal, 2011, vol. 32, no. 6, p. 760-771
|
In: European Heart Journal, 2009, vol. 30, no. 19, p. 2295-2296
|
In: Circulation: Cardiovascular Interventions, 2015, vol. 8, no. 10, p. e002518
Background—Everolimus-eluting bioresorbable vascular scaffolds have been developed to improve late outcomes after coronary interventions. However, recent registries raised concerns regarding an increased incidence of scaffold thrombosis (ScT). The mechanism of ScT remains unknown.Methods and Results—The present study investigated angiographic and optical...
|